Creavo Medical Technologies (Creavo) is pleased to announce the enrolment of the last patient in a study led by the cardiology team at the South Warwickshire NHS Foundation Trust. The study will assess if Creavo’s magnetocardiography (MCG) device can differentiate between the hearts of those who have previously suffered from a cardiac event such as … Continue reading Final patient enrolled in Creavo and University of Warwick MCG study
A new cardiac diagnostic device aimed at helping physicians rule out active ischemia in patients presenting to the emergency department (ED) with chest pain is being trialled at five of the most respected research facilities in the United States (Mayo Clinic, Rochester, MN; Baylor University, Houston, TX; Vanderbilt University, Nashville, TN; University of Cincinnati, OH; … Continue reading Creavo launches largest US study of its kind
It all began in 1948 when Aneurin Bevan established the National Health Service based on the premise that good healthcare should be available to all, regardless of wealth. 70 years on and the NHS sees almost 1.5 million patients every day in England alone. It has provided an incredible platform for the UK’s scientific community … Continue reading Celebrating with the NHS – 70 years of life-saving medical developments
Event marks Royal College of Physicians’ 500th anniversary – celebrating innovation in medicine. Creavo Medical Technologies (Creavo) will be exhibiting at the Royal College of Physicians’ (RCP) annual conference: Innovation in Medicine 2018 – one of the UK’s most anticipated medical events of year. The packed schedule includes presentations from over 90 leading international experts, … Continue reading Creavo attends RCP annual conference
Creavo Medical Technologies (Creavo) is pleased to announce the start of a new study at St George’s, University of London, led by Dr Elijah Behr. The study will assess if Creavo’s magnetocardiography (MCG) device can identify Brugada syndrome (BrS) in patients, then use this information to classify a group at risk of sudden cardiac death … Continue reading Creavo begins 60 patient Brugada syndrome study at St George’s, University of London
Professor Ben Varcoe , Chief Scientific Officer of Creavo was interviewed by “Physics World on diagnostic imaging. Click here for more information.